Early diagnosis of acute coronary syndrome with sensitive troponin I and ischemia modified albumin

Iranian Cardiovascular Research Journal

Volumn 4, Issue 4, 2010, Pages 144-151

  Takhshid, M A ^a   Kojuri, J ^b   Tabei, S M B ^c   Tavasouli, A R ^a   Heidary, S ^a   Tabandeh, M ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acute coronary syndrome; Cardiac troponin; Ischemia modified albumin

Indexed keywords

ISCHEMIA MODIFIED ALBUMIN; TROPONIN I;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; ELECTROCARDIOGRAM; EMERGENCY WARD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; THORAX PAIN;

EID: 79953310598     PISSN: 1735885X     EISSN: 17358868     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Storrow AB, Gibler WB. Chest pain centers: diagnosis of acute coronary syndromes. Ann Emerg Med 2000;35:449-61. [10783407]
2. Morrow DA, Rifai N, Tanasijevic MJ, Wybenga DR, de Lemos JA, Antman EM. Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a Thrombolysis in Myocardial Infarction (TIMI) 11B substudy. Clin Chem 2000;46:453-60. [10759468]
3. Panteghini M. Acute coronary syndrome: biochemical strategies in the troponin era. Chest 2002;122:1428-35. [12377875]
4. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000;36:959-69.[10987628]
5. Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined-a consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J 2000;21:1502-13.[10973764]
6. Melanson SE, Morrow DA, Jarolim P. Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity. Am J Clin Pathol 2007;128:282-6. [17638663]
7. Wu AH, Agee SJ, Lu QA, Todd J, Jaffe AS. Specificity of a high-sensitivity cardiac troponin I assay using single-molecule counting technology. Clin Chem 2009;55:196-8. [19106190]
8. Kavsak PA, MacRae AR, Lustig V, Bhargava R, Vandersluis R, Palomaki GE, et al. The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction. Am Heart J 2006;152:118-25. [16824840]
9. Lin JC, Apple FS, Murakami MM, Luepker RV. Rates of positive cardiac troponin I and creatine kinase MB among patients hospitalized for suspected acute coronary syndromes. Clin Chem 2004;50:333-8. [14670826]
10. Collinson PO, Gaze DC. Ischemia-modified albumin: clinical utility and pitfalls in measurement. J Clin Pathol 2008;61:1025-8. [18755726]
11. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia - a preliminary report. J Emerg Med 2000;19:311-15. [11074321]
12. Bhagavan NV, Lai EM, Rios PA, et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem 2003;49:581-5. [12651810]
13. Christenson RH, Duh SH, Sanhai WR, Wu AH, Holtman V, Painter P, et al. Characteristics of an albumin cobalt binding test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 2001;47:464-70. [1123829]
14. Gaze DC, Crompton L, Collinson P. Ischemia-modified albumin concentrations should be interpreted with caution in patients with low serum albumin concentrations. Med Princ Pract 2006;15:322-4. [16763404]
15. Lee YW, Kim HJ, Cho YH, Shin HB, Choi TY, Lee YK. Application of albumin-adjusted ischemia modified albumin index as an early screening marker for acute coronary syndrome. Clin Chim Acta 2007;384: 24-7. [17570353]
16. Lippi G, Montagnana M, Salvagno GL, Guidi GC. Standardization of ischemia-modified albumin testing: adjustment for serum albumin. Clin Chem Lab Med 2007;45:261-2. [17311519]
17. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 2007;50:e1-157. [17692738]
18. Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, et al. On behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the redefinition of myocardial infarction. Eur Heart J 2007;28:2525-38. [17951287]
19. Perry BW, Doumas BT. Effect of heparin on albumin determination by use of Bromcresol Green and Bromcresol Purple. Clin Chem 1979;25:1520-2. [455712]
20. Anwaruddin S, Januzzi JL, Baggish AL, Lewandrowski EL, Lewandrowski KB. Ischemia modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting. Am J Clin Pathol 2005;123:140-5. [15762290]
21. Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC. Role of "Ischemia Modified Albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004;21:29-34. [14734370]
22. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez MJ, Samimi-Fard S, Reiter RJ, Kaski JC. Association of ischemia-modified albumin and melatonin in patients with ST-elevation myocardial infarction. Atherosclerosis 2008;199:73-8. [18054940]
23. Mothes E, Faller P. Evidence that the principal CoII binding site in human serum albumin is not at the N terminus: implication on the albumin cobalt binding test for detecting myocardial ischemia. Biochemistry 2007;46:2267-74. [17274600]
24. Roy D, Quiles J, Aldama G, Sinha M, Avanzas P, Arroyo-Espliguero R, et al. Ischemia modified albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol 2004;97:297-301. [15458698]
25. Apple FS, Smith SW, Pearce LA, Ler R, Murakami MM, Benoit MO, et al. Use of the bioMérieux VIDAS troponin I ultra assay for the diagnosis of myocardial infarction and detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chim Acta 2008;390:72-5. [182303]
26. Tucker JF, Collins RA, Anderson AJ, Hauser J, Kalas J, Apple FS. Early diagnostic efficacy of cardiac troponin I and T for acute myocardial infarction. Acad Emerg Med 1997;4:13-21. [9110006]
27. Zimmerman J, Fromm R, Meyer D, Boudreaux A, Wu CCC, Smalling R, et al. Diagnostic marker cooperative study for the diagnosis of myocardial infarction. Circulation 1999;99:1671-167. [8970353]
28. Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernández-Avilés F, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007; 28:1598-60. [17569677]